BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 29958939)

  • 1. Mutational landscape of a chemically-induced mouse model of liver cancer.
    Connor F; Rayner TF; Aitken SJ; Feig C; Lukk M; Santoyo-Lopez J; Odom DT
    J Hepatol; 2018 Oct; 69(4):840-850. PubMed ID: 29958939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the Ha-ras oncogene in C3H/He mouse liver tumours derived spontaneously or induced with diethylnitrosamine or phenobarbitone.
    Rumsby PC; Barrass NC; Phillimore HE; Evans JG
    Carcinogenesis; 1991 Dec; 12(12):2331-6. PubMed ID: 1747936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Point mutation analysis of ras genes in spontaneous and chemically induced C57Bl/10J mouse liver tumours.
    Lord PG; Hardaker KJ; Loughlin JM; Marsden AM; Orton TC
    Carcinogenesis; 1992 Aug; 13(8):1383-7. PubMed ID: 1499088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth characteristics and Ha-ras mutations of cell cultures isolated from chemically induced mouse liver tumours.
    Pedrick MS; Rumsby PC; Wright V; Phillimore HE; Butler WH; Evans JG
    Carcinogenesis; 1994 Sep; 15(9):1847-52. PubMed ID: 7522981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete response of Ctnnb1-mutated tumours to β-catenin suppression by locked nucleic acid antisense in a mouse hepatocarcinogenesis model.
    Delgado E; Okabe H; Preziosi M; Russell JO; Alvarado TF; Oertel M; Nejak-Bowen KN; Zhang Y; Monga SP
    J Hepatol; 2015 Feb; 62(2):380-7. PubMed ID: 25457204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mutational landscapes of genetic and chemical models of Kras-driven lung cancer.
    Westcott PM; Halliwill KD; To MD; Rashid M; Rust AG; Keane TM; Delrosario R; Jen KY; Gurley KE; Kemp CJ; Fredlund E; Quigley DA; Adams DJ; Balmain A
    Nature; 2015 Jan; 517(7535):489-92. PubMed ID: 25363767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrative genomic analysis of mouse and human hepatocellular carcinoma.
    Dow M; Pyke RM; Tsui BY; Alexandrov LB; Nakagawa H; Taniguchi K; Seki E; Harismendy O; Shalapour S; Karin M; Carter H; Font-Burgada J
    Proc Natl Acad Sci U S A; 2018 Oct; 115(42):E9879-E9888. PubMed ID: 30287485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ras oncogene mutations in diethylnitrosamine-induced hepatic tumors in medaka (Oryzias latipes), a teleost fish.
    Liu Z; Kullman SW; Bencic DC; Torten M; Hinton DE
    Mutat Res; 2003 Aug; 539(1-2):43-53. PubMed ID: 12948813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation.
    Abitbol S; Dahmani R; Coulouarn C; Ragazzon B; Mlecnik B; Senni N; Savall M; Bossard P; Sohier P; Drouet V; Tournier E; Dumont F; Sanson R; Calderaro J; Zucman-Rossi J; Vasseur-Cognet M; Just PA; Terris B; Perret C; Gilgenkrantz H
    J Hepatol; 2018 Jun; 68(6):1203-1213. PubMed ID: 29525529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for p53 mutations in C3H/He mouse liver tumors derived spontaneously or induced with diethylnitrosamine or phenobarbitone.
    Rumsby PC; Davies MJ; Evans JG
    Mol Carcinog; 1994 Feb; 9(2):71-5. PubMed ID: 8142011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Frequency of β-Catenin Mutations in Mouse Hepatocellular Carcinomas Induced by a Nongenotoxic Constitutive Androstane Receptor Agonist.
    Mattu S; Saliba C; Sulas P; Zavattari P; Perra A; Kowalik MA; Monga SP; Columbano A
    Am J Pathol; 2018 Nov; 188(11):2497-2507. PubMed ID: 30201494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of β-catenin gene mutations and gene expression in liver tumours of C57BL/10J mice produced by chronic administration of sodium phenobarbital.
    Sidaway JE; Orton TC; Kalaitzi K; Jones HB; Foster A; Lake BG
    Toxicology; 2020 Jan; 430():152343. PubMed ID: 31836555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ras mutations in methylclofenapate-induced B6C3F1 and C57BL/10J mouse liver tumours.
    Stanley LA; Blackburn DR; Devereaux S; Foley J; Lord PG; Maronpot RR; Orton TC; Anderson MW
    Carcinogenesis; 1994 Jun; 15(6):1125-31. PubMed ID: 8020144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective pressure during tumor promotion by phenobarbital leads to clonal outgrowth of beta-catenin-mutated mouse liver tumors.
    Aydinlik H; Nguyen TD; Moennikes O; Buchmann A; Schwarz M
    Oncogene; 2001 Nov; 20(53):7812-6. PubMed ID: 11753661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RSK2 inactivation cooperates with AXIN1 inactivation or β-catenin activation to promote hepatocarcinogenesis.
    Schaeffer S; Gupta B; Calatayud AL; Calderaro J; Caruso S; Hirsch TZ; Pelletier L; Zucman-Rossi J; Rebouissou S
    J Hepatol; 2023 Sep; 79(3):704-716. PubMed ID: 37201672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Notch activity characterizes a common hepatocellular carcinoma subtype with unique molecular and clinicopathologic features.
    Zhu C; Ho YJ; Salomao MA; Dapito DH; Bartolome A; Schwabe RF; Lee JS; Lowe SW; Pajvani UB
    J Hepatol; 2021 Mar; 74(3):613-626. PubMed ID: 33038431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancer.
    Schneider C; Teufel A; Yevsa T; Staib F; Hohmeyer A; Walenda G; Zimmermann HW; Vucur M; Huss S; Gassler N; Wasmuth HE; Lira SA; Zender L; Luedde T; Trautwein C; Tacke F
    Gut; 2012 Dec; 61(12):1733-43. PubMed ID: 22267597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole exome sequencing of an asbestos-induced wild-type murine model of malignant mesothelioma.
    Sneddon S; Patch AM; Dick IM; Kazakoff S; Pearson JV; Waddell N; Allcock RJN; Holt RA; Robinson BWS; Creaney J
    BMC Cancer; 2017 Jun; 17(1):396. PubMed ID: 28577549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of DEN-induced liver tumourigenesis in hepatocyte-specific Lass2-knockout mice coincident with upregulation of the TGF-β1-Smad4-PAI-1 axis.
    Chen L; Lu X; Zeng T; Chen Y; Chen Q; Wu W; Yan X; Cai H; Zhang Z; Shao Q; Qin W
    Oncol Rep; 2014 Feb; 31(2):885-93. PubMed ID: 24337404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the Ha-, Ki-, and N-ras genes in chemically induced liver tumors from CD-1 mice.
    Manam S; Storer RD; Prahalada S; Leander KR; Kraynak AR; Ledwith BJ; van Zwieten MJ; Bradley MO; Nichols WW
    Cancer Res; 1992 Jun; 52(12):3347-52. PubMed ID: 1596892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.